01:08 PM EST, 11/24/2025 (MT Newswires) -- Health care stocks rose Monday afternoon, with the NYSE Health Care Index up 0.5% and the Health Care Select Sector SPDR Fund (XLV) adding 0.7%.

The iShares Biotechnology ETF (IBB) advanced 1%.

In corporate news, Eli Lilly ( LLY ) is benefiting from the "broadening" GLP-1 market for obesity and type-2 diabetes, Morgan Stanley said. The brokerage said in a note that the glucagon-like peptide-1, or GLP-1, market will continue to grow for both obesity and type-2 diabetes. Morgan Stanley raised the stock's price target to $1,290 from $1,171, while keeping the company's overweight rating. Eli Lilly ( LLY ) shares were up 0.3%.